Alkermes (ALKS) Shares Outstanding (Diluted Average) (2011 - 2023)

Alkermes (ALKS) reported Shares Outstanding (Diluted Average) of $169.7 million for Q4 2023, up 3.66% year-over-year from $163.7 million in Q4 2022, and up 2.81% quarter-over-quarter from $165.1 million in Q1 2023.

Alkermes (ALKS) Shares Outstanding (Diluted Average) (2011 - 2023) Analysis & Trends

Alkermes (ALKS) has 8 years of Shares Outstanding (Diluted Average) data on file, last reported at $169.7 million in Q4 2023.

  • Shares Outstanding (Diluted Average) for Q4 2023 came in at $169.7 million, up 3.66% year-over-year; the trailing twelve-month figure through Dec 2023 was $169.7 million (up 3.66% YoY), and the FY2023 annual result was $169.7 million, up 3.66% from the prior year.
  • Shares Outstanding (Diluted Average) grew to $169.7 million in Q4 2023 per ALKS's latest filing, from $165.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $169.7 million in Q4 2023 and troughed at $158.8 million in Q4 2020.
  • A 4-year average of $163.6 million and a median of $163.6 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Diluted Average) climbed 3.75% in 2021, then decreased 0.61% in 2022.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $158.8 million in 2020, then gained by 3.75% to $164.8 million in 2021, then fell by 0.61% to $163.7 million in 2022, then advanced by 3.66% to $169.7 million in 2023.
  • Business Quant data shows ALKS's Shares Outstanding (Diluted Average) at $169.7 million in Q4 2023, $165.1 million in Q1 2023, and $163.7 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.18 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn 101.11 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 169.73 Mn
Mar 31, 2023 165.09 Mn
Dec 31, 2022 163.74 Mn
Sep 30, 2022 163.54 Mn
Mar 31, 2022 162.48 Mn
Dec 31, 2021 164.75 Mn
Sep 30, 2021 160.64 Mn
Dec 31, 2020 158.80 Mn
Jun 30, 2014 144.14 Mn
Mar 31, 2014 143.36 Mn
Sep 30, 2013 135.36 Mn
Jun 30, 2013 141.82 Mn
Mar 31, 2013 139.68 Mn
Sep 30, 2012 135.59 Mn
Mar 31, 2012 114.70 Mn
Sep 30, 2011 102.47 Mn
Mar 31, 2011 95.61 Mn